Polyethylene Glycol 300
Excipient (pharmacologically inactive substance)
What is Polyethylene Glycol 300?
Polyethylene glycol, referred to as PEG, is used as an inactive ingredient in the pharmaceutical industry as a solvent, plasticizer, surfactant, ointment and suppository base, and tablet and capsule lubricant. PEG has low toxicity with systemic absorption less than 0.5%. PEGylation occurs when PEGs are attached to various protein medications, allowing for greater solubility for certain drugs. Examples of PEGylated medications include PEG-interferon alpha (Pegintron) and PEG-filgrastim (Neulasta). PEG is also available as a bowel prep for colonoscopy procedures and as a laxative. PEG 400 indicates the average molecular weight of the specific PEG at 400. PEG 3350 is a laxative available over-the-counter by the name of Miralax. In this case, PEG is considered an active ingredient, even though systemic absorption is less than 0.5%.
 Dave RH. Overview of pharmaceutical excipients used in tablets and capsules. Drug Topics (online). Advanstar. 10/24/2008 http://drugtopics.modernmedicine.com/drugtopics/Top+News/Overview-of-pharmaceutical-excipients-used-in-tabl/ArticleStandard/Article/detail/561047. Accessed 08/19/2011
Top Medications Containing Polyethylene Glycol 300
- Caprelsa 100 mg (Astra-Zeneca Pharmaceuticals)
- Caprelsa 300 mg (AstraZeneca Pharmaceuticals)
- Escitalopram Oxalate 10 mg (base) (West-Ward Pharmaceutical Company)
- Escitalopram Oxalate 20 mg (base) (West-Ward Pharmaceutical Company)
- Escitalopram Oxalate 5 mg (base) (West-Ward Pharmaceutical Company)
- Iressa 250 mg (AstraZeneca Pharmaceuticals)
- Vandetanib 300 mg (Astra-Zeneca Pharmaceuticals)